Cost-effectiveness of arthroscopic partial meniscectomy versus physical therapy for traumatic meniscal tears in patients aged under 45 years

Sabine J.A. van der Graaff, Max Reijman (Corresponding author), Duncan E. Meuffels, Marc A. Koopmanschap, STARR Study Group, Rob P.A. Janssen

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
47 Downloads (Pure)

Abstract

AIMS: The aim of this study was to evaluate the cost-effectiveness of arthroscopic partial meniscectomy versus physical therapy plus optional delayed arthroscopic partial meniscectomy in young patients aged under 45 years with traumatic meniscal tears.

METHODS: We conducted a multicentre, open-labelled, randomized controlled trial in patients aged 18 to 45 years, with a recent onset, traumatic, MRI-verified, isolated meniscal tear without knee osteoarthritis. Patients were randomized to arthroscopic partial meniscectomy or standardized physical therapy with an optional delayed arthroscopic partial meniscectomy after three months of follow-up. We performed a cost-utility analysis on the randomization groups to compare both treatments over a 24-month follow-up period. Cost utility was calculated as incremental costs per quality-adjusted life year (QALY) gained of arthroscopic partial meniscectomy compared to physical therapy. Calculations were performed from a healthcare system perspective and a societal perspective.

RESULTS: A total of 100 patients were included: 49 were randomized to arthroscopic partial meniscectomy and 51 to physical therapy. In the physical therapy group, 21 patients (41%) received delayed arthroscopic partial meniscectomy during follow-up. Over 24 months, patients in the arthroscopic partial meniscectomy group had a mean 0.005 QALYs lower quality of life (95% confidence interval -0.13 to 0.14). The cost-utility ratio was €-160,000/QALY from the healthcare perspective and €-223,372/QALY from the societal perspective, indicating that arthroscopic partial meniscectomy incurs additional costs without any added health benefit.

CONCLUSION: Arthroscopic partial meniscectomy is arthroscopic partial meniscectomy is unlikely to be cost-effective in treating young patients with isolated traumatic meniscal tears compared to physical therapy as a primary health intervention. Arthroscopic partial meniscectomy leads to a similar quality of life, but higher costs, compared to physical therapy plus optional delayed arthroscopic partial meniscectomy.

Original languageEnglish
Pages (from-to)1177-1183
Number of pages7
JournalThe Bone & Joint Journal
Volume105-B
Issue number11
DOIs
Publication statusPublished - 1 Nov 2023

Funding

The authors disclose receipt of the following financial or material support for the research, authorship, and/or publication of this article: we received a grant for this study from ZonMw, a Dutch organization for health research and care innovation. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The authors thank all researchers and patients of the participating hospitals: Catharina Hospital, Elisabeth Tweesteden Hospital, Erasmus MC University Medical Centre, Haaglanden Medical Centre, Máxima Medical Centre, Noordwest Hospital Group, OLVG and St. Antonius Hospital. Open access funding was provided by the Department of Orthopaedics and Sports Medicine of the Erasmus MC University Medical Centre.

FundersFunder number
Erasmus University Medical Center
Máxima Medical Center
Noordwest Ziekenhuisgroep
Haaglanden Medical Center
ZonMw : Dutch Organisation for Health Research and Development
St. Antonius Ziekenhuis

    Keywords

    • Humans
    • Meniscectomy/adverse effects
    • Cost-Benefit Analysis
    • Quality of Life
    • Physical Therapy Modalities
    • Osteoarthritis, Knee/surgery
    • Arthroscopy/adverse effects
    • Menisci, Tibial/surgery

    Fingerprint

    Dive into the research topics of 'Cost-effectiveness of arthroscopic partial meniscectomy versus physical therapy for traumatic meniscal tears in patients aged under 45 years'. Together they form a unique fingerprint.

    Cite this